"Drug delivery session" driven by SFNanomedicine french association

13:30 • 2392 • Elastin-like polypeptides-based nanoparticles: strengths and weaknesses for drug delivery applications > E. Elisabeth GARANGER (Pessac) 14:00 • 2042 • Novel liposomal nanoformulation targeting NLRP3 inflammasome for treating hepatocellular carcinoma: synthesis, characterization, in vitro and in vivo studies > R. Rita MASTROGIACOMO (Bari) 14:15 • 2263 • Elaboration of Crystalline Nanoparticles for Theranostic and Drug Delivery Applications > Y. Yohann CORVIS (Paris) 14:30 • 2128 • Design of a viral-inspired nanoparticle for translational studies in infectiology and cancer > P. Pascal FENDER (Grenoble) 15:00 • 2129 • Magnetic nanoparticles-conjugated E. coli as a potent drug delivery agent for multimodal therapy of pancreatic cancer > T. Tashmeen KAUR (Mohali) 15:15 • 1009 • Escherichia coli adhesin protein-conjugated thermal responsive hybrid nanoparticles for photothermal and immunotherapy against cancer and its metastasis > J. Juyoung HWANG (Busan) 15:30 • 737 • Evolution of Chameleon Nanocarriers: RNA Transfer at Ultra-low Picogram Dose > E. Ernst WAGNER (Munich)